Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 16.16 is 220% above its 5-year average of 5.05, near the high end of its 5-year range (0.92–19.81).
As of the fiscal period ended Tuesday, June 30, 2026. 36.08% above its 12-month average of 11.88.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.16.
QUICK RATIO (ACID-TEST)
16.16
QUICK RATIO (ACID-TEST) AVG TTM
11.88
QUICK RATIO (ACID-TEST) AVG 3Y
4.66
QUICK RATIO (ACID-TEST) AVG 5Y
5.05
QUICK RATIO (ACID-TEST) AVG 10Y
8.18
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+36.08%
CURRENT VS 3Y AVG
+247.10%
CURRENT VS 5Y AVG
+220.21%
CURRENT VS 10Y AVG
+97.55%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+381.72%
vs the sector median at left
Corvus Pharmaceuticals, Inc.
Market Cap
$887.99M
Quick Ratio (Acid-Test)
16.16
TTM Avg
11.88
3Y Avg
4.66
5Y Avg
5.05
Market Cap
$887.50M
Quick Ratio (Acid-Test)
1.17
TTM Avg
1.03
3Y Avg
0.92
5Y Avg
1.05
Market Cap
$884.97M
Quick Ratio (Acid-Test)
81.42
TTM Avg
11.94
3Y Avg
8.59
5Y Avg
10.34
Market Cap
$870.81M
Quick Ratio (Acid-Test)
11.36
TTM Avg
7.20
3Y Avg
7.20
5Y Avg
7.20
Market Cap
$867.03M
Quick Ratio (Acid-Test)
7.55
TTM Avg
6.94
3Y Avg
6.93
5Y Avg
8.87
Market Cap
$914.73M
Quick Ratio (Acid-Test)
1.06
TTM Avg
1.14
3Y Avg
1.09
5Y Avg
1.06
Market Cap
$857.16M
Quick Ratio (Acid-Test)
0.76
TTM Avg
0.79
3Y Avg
0.88
5Y Avg
1.73
Market Cap
$921.06M
Quick Ratio (Acid-Test)
12.56
TTM Avg
15.19
3Y Avg
22.99
5Y Avg
17.56
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | $887.99M | 16.16 | 11.88 | 4.66 | 5.05 |
| Bioventus Inc. (BVS)vs › | $887.50M | 1.17 | 1.03 | 0.92 | 1.05 |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | 81.42 | 11.94 | 8.59 | 10.34 |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | 11.36 | 7.20 | 7.20 | 7.20 |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | 7.55 | 6.94 | 6.93 | 8.87 |
| HealthStream, Inc. (HSTM)vs › | $914.73M | 1.06 | 1.14 | 1.09 | 1.06 |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | 0.76 | 0.79 | 0.88 | 1.73 |
| Alumis Inc. (ALMS)vs › | $855.38M | 6.74 | 5.17 | 5.15 | 5.15 |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | 12.56 | 15.19 | 22.99 | 17.56 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 1.79 | 2.17 | 1.93 | 2.04 |
Quick Ratio
16.16
Excludes inventory
Current Ratio
16.16
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 16.16 |
| 2026-03-31 | 19.81 |
| 2025-12-31 | 6.21 |
| 2025-09-30 | 8.29 |
| 2025-06-30 | 8.91 |
| 2025-03-31 | 4.90 |
| 2024-12-31 | 1.54 |
| 2024-09-30 | 0.92 |
| 2024-06-30 | 3.62 |
| 2024-03-31 | 3.40 |
| 2023-12-31 | 4.07 |
| 2023-09-30 | 4.53 |
| 2023-06-30 | 4.82 |
| 2023-03-31 | 4.29 |
| 2022-12-31 | 4.06 |
| 2022-09-30 | 3.67 |
| 2022-06-30 | 5.80 |
| 2022-03-31 | 6.95 |
| 2021-12-31 | 7.36 |
| 2021-09-30 | 6.97 |
| 2021-06-30 | 5.59 |
| 2021-03-31 | 4.94 |
| 2020-12-31 | 3.73 |
| 2020-09-30 | 4.38 |
| 2020-06-30 | 5.24 |
| 2020-03-31 | 5.96 |
| 2019-12-31 | 7.76 |
| 2019-09-30 | 10.07 |
| 2019-06-30 | 9.12 |
| 2019-03-31 | 12.34 |
| 2018-12-31 | 14.59 |
| 2018-09-30 | 16.05 |
| 2018-06-30 | 13.71 |
| 2018-03-31 | 13.64 |
| 2017-12-31 | 9.15 |
| 2017-09-30 | 10.08 |
| 2017-06-30 | 11.71 |
| 2017-03-31 | 16.22 |
| 2016-12-31 | 18.51 |
| 2016-09-30 | 26.06 |
| 2016-06-30 | 42.55 |
| 2016-03-31 | 45.33 |
| 2015-12-31 | 30.93 |
| 2015-09-30 | 111.05 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 4.69 |
